It's nicely recognized that IL-2 is a pleiotropic cytokine positioned within the crossroads of T cell activation and regulation. As a result, it's very important to engineer an IL-two molecule that may be biased in direction of effector cells bearing the intermediate affinity receptor, which include naïve and memory CD8+ T cells and NK cells, comp